Calliditas Therapeutics AB Balance Sheet

Ask AI

Financial Statements

In millions of SEK, except per-share amounts

	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021
ASSETS
Non-current assets
Intangible assets
Goodwill
Equipment
Right-of-use assets
Non-current financial assets
Deferred tax assets
Total non-current assets
Current assets
Inventories
Accounts receivable
Other current assets
Prepaid expenses and accrued income
Cash
Total current assets
TOTAL ASSETS
EQUITY AND LIABILITIES
Equity
Share capital
Additional paid-in capital
Reserves
Retained earnings including net loss for the year
Total equity attributable to equity holders of the Parent Company
Non-current liabilities
Provisions
Contingent consideration
Pension liabilities
Deferred tax liabilities
Non-current interest-bearing liabilities
Non-current lease liabilities
Other non-current liabilities
Total non-current liabilities
Current liabilities
Accounts payable
Current tax liabilities
Other current liabilities
Accrued expenses and deferred revenue
Total current liabilities
TOTAL EQUITY AND LIABILITIES

Comments